189 related articles for article (PubMed ID: 29698469)
21. Epigenetic changes during hematopoietic cell granulocytic differentiation--comparative analysis of primary CD34+ cells, KG1 myeloid cells and mature neutrophils.
Navakauskienė R; Borutinskaitė VV; Treigytė G; Savickienė J; Matuzevičius D; Navakauskas D; Magnusson KE
BMC Cell Biol; 2014 Jan; 15():4. PubMed ID: 24443786
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.
Bartels M; Geest CR; Bierings M; Buitenhuis M; Coffer PJ
Haematologica; 2010 Jul; 95(7):1052-60. PubMed ID: 20107159
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors.
Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P
Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882
[TBL] [Abstract][Full Text] [Related]
24. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
Cheng L; Qasba P; Vanguri P; Thiede MA
J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
[TBL] [Abstract][Full Text] [Related]
25. Current understanding of human megakaryocytic-erythroid progenitors and their fate determinants.
Kwon N; Thompson EN; Mayday MY; Scanlon V; Lu YC; Krause DS
Curr Opin Hematol; 2021 Jan; 28(1):28-35. PubMed ID: 33186151
[TBL] [Abstract][Full Text] [Related]
26. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
27. Identification of unipotent megakaryocyte progenitors in human hematopoiesis.
Miyawaki K; Iwasaki H; Jiromaru T; Kusumoto H; Yurino A; Sugio T; Uehara Y; Odawara J; Daitoku S; Kunisaki Y; Mori Y; Arinobu Y; Tsuzuki H; Kikushige Y; Iino T; Kato K; Takenaka K; Miyamoto T; Maeda T; Akashi K
Blood; 2017 Jun; 129(25):3332-3343. PubMed ID: 28336526
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
29. Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells.
Salati S; Zini R; Bianchi E; Testa A; Mavilio F; Manfredini R; Ferrari S
Stem Cells; 2008 Apr; 26(4):950-9. PubMed ID: 18192237
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the biological activities of anagrelide and its major metabolites in haematopoietic cell cultures.
Wang G; Franklin R; Hong Y; Erusalimsky JD
Br J Pharmacol; 2005 Oct; 146(3):324-32. PubMed ID: 16041400
[TBL] [Abstract][Full Text] [Related]
31. Single-cell approaches reveal novel cellular pathways for megakaryocyte and erythroid differentiation.
Psaila B; Mead AJ
Blood; 2019 Mar; 133(13):1427-1435. PubMed ID: 30728145
[TBL] [Abstract][Full Text] [Related]
32. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
34. Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C.
Proulx C; Dupuis N; St-Amour I; Boyer L; Lemieux R
Biotechnol Bioeng; 2004 Dec; 88(6):675-80. PubMed ID: 15532059
[TBL] [Abstract][Full Text] [Related]
35. miRNAs can increase the efficiency of ex vivo platelet generation.
Emmrich S; Henke K; Hegermann J; Ochs M; Reinhardt D; Klusmann JH
Ann Hematol; 2012 Nov; 91(11):1673-84. PubMed ID: 22763947
[TBL] [Abstract][Full Text] [Related]
36. Enrichment and characterization of peripheral blood-derived megakaryocyte progenitors that mature in short-term liquid culture.
Nichol JL; Hornkohl AC; Choi ES; Hokom MM; Ponting I; Schuening FW; Hunt P
Stem Cells; 1994 Sep; 12(5):494-505. PubMed ID: 7528590
[TBL] [Abstract][Full Text] [Related]
37. Effects of histone deacetylase inhibitor valproic acid on skeletal myocyte development.
Li Q; Foote M; Chen J
Sci Rep; 2014 Nov; 4():7207. PubMed ID: 25423891
[TBL] [Abstract][Full Text] [Related]
38. Lymphoid-affiliated genes are associated with active histone modifications in human hematopoietic stem cells.
Maës J; Maleszewska M; Guillemin C; Pflumio F; Six E; André-Schmutz I; Cavazzana-Calvo M; Charron D; Francastel C; Goodhardt M
Blood; 2008 Oct; 112(7):2722-9. PubMed ID: 18625888
[TBL] [Abstract][Full Text] [Related]
39. [In vitro expansion of cord blood megakaryocyte progenitor].
Feng Y; Xiao ZJ; Xu SC; Lu SH; Liu B; Liu JH; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):199-204. PubMed ID: 15960266
[TBL] [Abstract][Full Text] [Related]
40. Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling.
Gul H; Marquez-Curtis LA; Jahroudi N; Lo J; Turner AR; Janowska-Wieczorek A
Stem Cells Dev; 2009; 18(6):831-8. PubMed ID: 18847317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
